Evaluation research of implementing intensity-modulated verification of individualization for patient based on various dosimetric tools
杨涛,曲宝林,徐寿平,戴相昆,解传滨,丛小虎,王小深,王金媛,龚璇
DOI: https://doi.org/10.3969/J.ISSN.1672-8270.2018.07.001
2018-01-01
Abstract:Objective: To evaluate the method that implemented intensity-modulated verification of individualization for patient based on various dosimetric tool so as to provide some bases and choices for clinical work.Methods: The volumetric modulated arc therapy(VMAT)plans of 12 patients who were waiting verification were randomly selected,and all of them were radiated by using Varian Clinac iX accelerator with electronic portal imaging device(EPID).Through the verification of absolute dosage,the verification pre-treatment plan and the in-vivo verification of dosage in treatment,the different dosage tools were applied to carry out quantitative evaluation analysis.And series of treatment planning system software included the MobiusFX,EPIgray/EPIbeam,SNCPatient/3DVH and Eclipse were used to reconstruct dosage,and the hardware of dosage measure included A1SL ionization chamber,Cheese phantom,ArcCheck and EPID.Besides,the logfiles of implemented plan were adopted to carry out dosage verification.Results: The mean relative deviations between the central point of field,that measured by using EPIgray,MobiusFX and ionization chamber,and the theoretical value of treatment plan system(TPS)were(1.78±1.22)％,(2.38±0.88)％and(2.96±0.86)％,respectively,which were within the standard range of 5％.Before treatment,the passing rates of 2D Gamma of planning verification(EPIbeam and SNCPatient)of 12 patients were(98.20±2.16％)and(98.15±1.73％),respectively,and the difference of passing rate between them was no significant(t=-0.078,P＞0.05).And the passing rates of 3D Gamma of 3D VH(99.16±1.81％)was slightly better than that of MobiusFX(98.12±1.36％),and all of them appeared better consistency.In dosage verification of in-vivo,the mean dosage deviation of EPIgray was(-2.47±1.48)％,and average passing rate of 3D Gamma of MobiusFX was(97.73±1.95)％.Conclusion: All of three different dosage verification tools can effectively implement patient-specific QA,and they have enhance safety of treatment for patient.